ANI Pharmaceuticals Announces FDA Approval And Launch Of Levocarnitine Tablets USP
ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Levocarnitine Tablets
